Related Experiment Video
Updated: Aug 21, 2026
Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Identifying patients at risk of intraoperative and postoperative transfusion in isolated CABG: toward selective
Rakesh C Arora1, Jean-Francois Légaré, Karen J Buth
1Division of Cardiac Surgery, Dalhousie University, Halifax, Nova Scotia, Canada.
Insights
A new model predicts allogeneic blood product transfusions in cardiac surgery patients. Identifying eight risk factors helps optimize blood conservation strategies and resource allocation for coronary artery bypass grafting (CABG) procedures.
Area of Science:
- Cardiovascular Surgery
- Transfusion Medicine
- Health Services Research
Background:
- Allogeneic blood product use in cardiac surgery frequently exceeds 40%, despite existing guidelines and conservation efforts.
- Developing accurate predictive models is crucial for managing blood product transfusions and associated costs.
Purpose of the Study:
- To develop and validate a predictive model for allogeneic blood product transfusion rates in patients undergoing cardiac procedures.
- To identify key preoperative risk factors associated with transfusion needs in coronary artery bypass graft (CABG) surgery.
Main Methods:
- A logistic regression model was developed using data from 3,046 isolated CABG procedures (1995-1998).
- The model identified eight independent predictors of allogeneic blood product transfusion.
- Internal validation was performed using a prospective sample of 2,117 CABG patients.
Main Results:
- The overall allogeneic blood product transfusion rate was 23% in the initial cohort.
- In elective, first-time isolated CABG cases, 16.9% received transfusions.
- Key predictors included low hemoglobin, emergent operation, renal failure, female sex, older age, reduced ejection fraction, redo procedures, and low body surface area.
- Prospective validation showed an observed-to-expected transfusion ratio of 1.06.
Conclusions:
- The validated logistic regression model accurately predicts allogeneic blood product use in isolated CABG patients.
- This risk model enables preoperative stratification, improving the rational allocation of blood conservation resources and blood bank supplies.
Background:
Allogeneic blood product use during cardiac operation is often reported to exceed 40% despite published guidelines and costly blood conservation strategies. We developed a predictive model, based on eight preoperative risk factors, of allogeneic blood product transfusion rates in patients undergoing a cardiac procedure.
Methods:
All 3,046 consecutive, isolated coronary artery bypass graft (CABG) procedures at a university hospital from 1995 to 1998 were included. A logistic regression model was created to identify independent predictors of allogeneic blood product transfusion. This model was validated using a prospective patient sample.
Results:
Overall use of allogeneic blood products was 23% with a crude operative mortality of 2.1%. In isolated, elective, first-time CABG cases, 16.9% received allogeneic blood products. Independent predictors of blood product usage in CABG patients were preoperative hemoglobin 12.0 or less, emergent operation, renal failure, female sex, age 70 years or older, left ventricular ejection fraction 0.40 or less, redo procedure, and low body surface area. Prospective validation of this model on 2,117 consecutive isolated CABG patients demonstrated an observed-to-expected allogeneic blood product transfusion rate ratio of 1.06.
Conclusions:
This internally validated logistic regression risk model is a sensitive and specific predictor of allogeneic blood product use in patients undergoing isolated CABG. Utilization of this model allows for preoperative risk stratification and may allow for more rational resource allocation of costly blood conservation strategies and blood bank resources.
